Vorsitz: J. Ehrlich (Wiesbaden), U. Schotten (Maastricht, NL)
| (V535) | Challenging electroanatomical mapping for scar dechanneling in a large animal model of myocardial infarction | |
| T. G. Plenge, J. Terporten, A. Maul, P. Rademann, C. Debuschewitz, J.-H. van den Bruck, J. Lüker, A. Sultan, A. Sterner-Kock, D. Ladage, D. Steven (Köln) | ||
| Diskussion | ||
| (V536) | Severe proarrhythmic effects of digitalis in ranolazine- and flecainide-pretreated hearts | |
| C. Ellermann, J. Wolfes, D. Puckhaber, N. Bögeholz, P. Leitz, F. Reinke, L. Eckardt, G. Frommeyer (Münster) | ||
| Diskussion | ||
| (V537) | Pharmacological suppression of atrial fibrillation by TASK-1 K+ channel blockade in a large animal model |
|
| C. Schmidt, F. Wiedmann, C. Beyersdorf, Z. Zhao, H. Lan, I. El-Battrawy, X. Li, S. Lang, G. Szabó, M. Karck, X. Zhou, I. Akin, M. Borggrefe, H. A. Katus, D. Thomas (Heidelberg, Mannheim) | ||
| Diskussion | ||
| (V538) | MicroRNA-21 predicts outcome in patients undergoing atrial fibrillation ablation | |
| M. Gramlich, Q. Zhou, C. Maleck, B. Neupane, D. Heinzmann, F. Stimpfle, M. Gawaz, J. Schreieck, P. Seizer (Tübingen) | ||
| Diskussion | ||
| (V539) | Characterization of the electrophysiologic effects of the polyphenols resveratrol and piceatannol in rabbit atria | |
| G. Frommeyer, J. Wolfes, C. Ellermann, D. Dechering, S. Kochhäuser, F. Reinke, L. Eckardt (Münster) | ||
| Diskussion | ||
| (V540) | Role of neuronal sodium channel NaV1.8 in cardiac electrophysiology | |
| S. Ahmad, N. Dybkova, S. Pabel, P. Tirilomis, N. Hartmann, P. Bengel, L. S. Maier, K. Streckfuß-Bömeke, G. Hasenfuß, S. T. Sossalla (Göttingen, Regensburg) | ||
| Diskussion |
| 12:30 - 13:00 | Mittagspause |